Sponsor
Jiangsu Hansoh Pharmaceutical Group Co. Ltd.
No. 9 Dongjin Road, Economic And Technical Development Zone, 222069
About the sponsor
Clinical research is centered on non-small cell lung cancer with EGFR mutations, reflecting a focused interest in targeted treatment options for genetically defined lung tumours. The sponsor’s work includes patients with advanced disease and the evaluation of precision oncology approaches in lung cancer care.
- EGFR-mutated lung cancer
- Advanced lung cancer
- Targeted cancer therapy
The clinical programme also extends to European participants with genetically linked lung cancer, indicating interest in broader application of oncology research across different patient populations.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.